BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20017828)

  • 1. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival.
    McFarlane PA
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):182-8. PubMed ID: 21252663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More frequent hemodialysis: back to the future?
    Rocco MV
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e1-9. PubMed ID: 17603969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short daily and nocturnal hemodialysis: new therapies for a new century?
    Rocco MV
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis dose and frequency.
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
    Zsom L; Zsom M; Fulop T; Flessner MF
    Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
    Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
    Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dose of dialysis in hemodialysis patients: impact on nutrition.
    Schulman G
    Semin Dial; 2004; 17(6):479-88. PubMed ID: 15660579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.